Content deleted Content added
added legal status in U.S. and Canada |
mNo edit summary |
||
Line 16: | Line 16: | ||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_US = OTC |
| legal_US = OTC |
||
| legal_status = OTC(Canada) |
| legal_status = [[Over-the-counter drug|OTC]]<small>([[Canada]])</small> |
||
| routes_of_administration = |
| routes_of_administration = |
||
}} |
}} |
Revision as of 03:07, 15 November 2008
Clinical data | |
---|---|
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Elimination half-life | 25 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.595 |
Chemical and physical data | |
Formula | C16H19BrN2 |
Molar mass | 319.24 g/mol g·mol−1 |
Dexbrompheniramine maleate is an antihistamine used to treat allergic conditions such as hay fever or urticaria. It is the pharmacologically active dextrorotatory isomer of brompheniramine. It is marketed under the name Drixoral, which is a combination of dexbrompheniramine and pseudoephedrine.